Matches in Nanopublications for { ?s ?p "[The loss of AP-2alpha and increased activity of cAMP-responsive element binding (CREB) protein are two hallmarks of malignant progression of cutaneous melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 11 of
11
with 100 items per page.
- NP770768.RAYU0FmvPydWxBlXKvNvuXzazrpfCJO1VSw0qZbrUSFsE130_assertion description "[The loss of AP-2alpha and increased activity of cAMP-responsive element binding (CREB) protein are two hallmarks of malignant progression of cutaneous melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP770768.RAYU0FmvPydWxBlXKvNvuXzazrpfCJO1VSw0qZbrUSFsE130_provenance.
- NP325297.RADoxf5f78mbk1rcWhqh0RLyMIH3xH0TNsp1E4NIirt1k130_assertion description "[The loss of AP-2alpha and increased activity of cAMP-responsive element binding (CREB) protein are two hallmarks of malignant progression of cutaneous melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP325297.RADoxf5f78mbk1rcWhqh0RLyMIH3xH0TNsp1E4NIirt1k130_provenance.
- NP503082.RA9JPMCMmIgMNSDT_C-hqPRTGU81CW14m7fYWc-Ec_1Jc130_assertion description "[The loss of AP-2alpha and increased activity of cAMP-responsive element binding (CREB) protein are two hallmarks of malignant progression of cutaneous melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP503082.RA9JPMCMmIgMNSDT_C-hqPRTGU81CW14m7fYWc-Ec_1Jc130_provenance.
- NP325238.RAfZ1HTOiTgK9lkb0ZD2VLWpHBLM9Y4wPQ2GQdv2U2fiM130_assertion description "[The loss of AP-2alpha and increased activity of cAMP-responsive element binding (CREB) protein are two hallmarks of malignant progression of cutaneous melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP325238.RAfZ1HTOiTgK9lkb0ZD2VLWpHBLM9Y4wPQ2GQdv2U2fiM130_provenance.
- assertion description "[The loss of AP-2alpha and increased activity of cAMP-responsive element binding (CREB) protein are two hallmarks of malignant progression of cutaneous melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP729163.RAcfbrFH36oW1e7t6eQbakDVLJ0PK-ignFD0oEj8E7oEM130_assertion description "[The loss of AP-2alpha and increased activity of cAMP-responsive element binding (CREB) protein are two hallmarks of malignant progression of cutaneous melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP729163.RAcfbrFH36oW1e7t6eQbakDVLJ0PK-ignFD0oEj8E7oEM130_provenance.
- assertion description "[The loss of AP-2alpha and increased activity of cAMP-responsive element binding (CREB) protein are two hallmarks of malignant progression of cutaneous melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP836014.RA7vzRqWg2vkgBnJUIMHnJes_jNPHGBbPI40qS0HV7toU130_assertion description "[The loss of AP-2alpha and increased activity of cAMP-responsive element binding (CREB) protein are two hallmarks of malignant progression of cutaneous melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP836014.RA7vzRqWg2vkgBnJUIMHnJes_jNPHGBbPI40qS0HV7toU130_provenance.
- NP836016.RA9Qolb1YmSGNaB3N8La5CDsZEiG2piyux4X-yd7fQtpk130_assertion description "[The loss of AP-2alpha and increased activity of cAMP-responsive element binding (CREB) protein are two hallmarks of malignant progression of cutaneous melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP836016.RA9Qolb1YmSGNaB3N8La5CDsZEiG2piyux4X-yd7fQtpk130_provenance.
- assertion description "[The loss of AP-2alpha and increased activity of cAMP-responsive element binding (CREB) protein are two hallmarks of malignant progression of cutaneous melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP836012.RAiEsQgf-1PVCF8ARRBw7qI1NfBAgmR3F7u_skIxoJwo8130_assertion description "[The loss of AP-2alpha and increased activity of cAMP-responsive element binding (CREB) protein are two hallmarks of malignant progression of cutaneous melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP836012.RAiEsQgf-1PVCF8ARRBw7qI1NfBAgmR3F7u_skIxoJwo8130_provenance.